ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma
Clinical trial NCT03003637 · COMPLETED
Trial details
- NCT number
- NCT03003637
- Sponsor
- The Netherlands Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2019-10-12
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.